专利检索 ap:("Novartis AG") AND inv:"FUREGATI, Markus" 第 1 页

1.

发明公开
PHARMACEUTICAL COMBINATION OF A TRICYCLIC BETA-LACTAMASE INHIBITOR WITH SPECIFIC BETA-LACTAM ANTIBIOTICS 审中-公开

公开(公告)号：EP3698796A1

公开(公告)日：2020-08-26

申请号：EP20165564.4

申请日：2017-09-28

申请人： Novartis AG

发明人： CASAREZ, Anthony , FUREGATI, Markus , KOCH, Guido , LIN, Xiaodong , OSSOLA, Flavio , RECK, Folkert , SIMMONS, Robert Lowell , ZHU, Qingming

IPC分类号： A61K31/535 , A61P31/04

摘要： This invention pertains generally to compounds of Formula (A),

as further described herein, which act as beta-lactamase inhibitors, and salts, crystalline forms and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds in combination with a beta-lactam antibiotic to treat infections caused by Gram-negative bacteria, including drug-resistant strains.

2.

发明授权
BETA-LACTAMASE INHIBITORS 有权

公开(公告)号：EP3519419B1

公开(公告)日：2020-05-27

申请号：EP17791737.4

申请日：2017-09-28

申请人： Novartis AG

发明人： CASAREZ, Anthony , FUREGATI, Markus , KOCH, Guido , LIN, Xiaodong , OSSOLA, Flavio , RECK, Folkert , SIMMONS, Robert Lowell , ZHU, Qingming

IPC分类号： C07D471/18 , A61K31/496 , A61K45/06 , A61K31/5025 , A61K31/551 , A61K31/546 , A61K31/407 , A61P31/04 , A61K31/427 , A61K31/431 , A61K31/4545

3.

发明公开
BETA-LACTAMASE INHIBITORS 审中-公开

公开(公告)号：EP3519419A1

公开(公告)日：2019-08-07

申请号：EP17791737.4

申请日：2017-09-28

申请人： Novartis AG

发明人： CASAREZ, Anthony , FUREGATI, Markus , KOCH, Guido , LIN, Xiaodong , OSSOLA, Flavio , RECK, Folkert , SIMMONS, Robert Lowell , ZHU, Qingming

IPC分类号： C07D519/06 , A61K31/535 , A61P31/04 , C07D471/18

摘要： as further described herein, which act as beta-lactamase inhibitors, and salts, crystalline forms and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds in combination with a beta-lactam antibiotic to treat infections caused by Gram-negative bacteria, including drug-resistant strains.

4.

发明公开
TRIAZOLO-PYRIMIDINE ANALOGUES FOR TREATING DISEASES CONNECTED TO THE INHIBITON OF WERNER SYNDROME RECQ HELICASE (WRN) 审中-实审

公开(公告)号：EP4347596A1

公开(公告)日：2024-04-10

申请号：EP22729790.0

申请日：2022-05-24

申请人： Novartis AG

发明人： BORDAS, Vincent , BRUN, Jvan , DECKER, Andrea , FUREGATI, Markus , GOGNIAT, Geoffrey , GONG, Wanben , HAMON, Jacques , HINRICHS, Juergen Hans-Hermann , HOLZER, Philipp , LIMAM, Fatma , MOEBITZ, Henrik , NOCITO, Sandro , PLATTNER, Simone , SCHMIEDEBERG, Niko , SCHOEPFER, Joseph , SOTO, Jessica , STRANG, Ross , YAO, Shuping , YU, Huangchao , ZECRI, Frédéric , ZHANG, Sisi

IPC分类号： C07D487/04 , A61P35/00 , A61K31/519